Search results
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
Motley Fool via Yahoo Finance· 2 days agoCathie Wood is buying the dip on two biotechs in particular, so for her, the answer to that question...
Here's How Cathie Wood (Almost) Completely Missed the Boat on Artificial Intelligence (AI) -- and...
The Motley Fool via AOL· 4 days ago...Tesla ARK Bitcoin ETF HoldCo Coinbase Global Tesla Twist Bioscience 2 Coinbase Global Tesla...
Cathie Wood's ARK buys PagerDuty, CRISPR, sells Zoom stock By Investing.com
Investing.com· 5 days agoCathie Wood's ARK buys PagerDuty, CRISPR, sells Zoom stock
Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You?
Motley Fool via Yahoo Finance· 6 days agoThis top investor is betting on various big names such as Tesla, her top holding, as well as smaller...
Cathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock By Investing.com
Investing.com· 6 days agoCathie Wood's ARK sells Robinhood, buys UiPath and Amgen stock
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 days agoVertex is also working on a next-generation triple regimen that proved non-inferior to the existing...
ASCO: Cautious Big Pharmas double down on past wins—steering clear of radioligands and cell therapy
FierceBiotech· 18 hours agoThis year’s American Society of Clinical Oncology (ASCO) conference in Chicago marked a return to...
Swiss biotech ecosystem recuperates from global financial instability
Pharmaceutical Technology via Yahoo Finance· 6 days agoIn March 2023, Zug, Switzerland-headquartered CRISPR Therapeutics closed a $330 million licensing...
Iridium secures $94 million Space Force contract By Investing.com
Investing.com· 2 days agoIridium secures $94 million Space Force contract
Triplet Notches Survival Win in Heavily Pretreated DLBCL
MedPage Today· 4 days agoBenefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant